Hera Health Solutions 的动态

Success Stories of Long-Acting Drugs (Pt. 2): ? Low patient compliance and repetitive treatments are signs that a long-acting drug can disrupt the market. Pfizer and OPKO entered 40+ markets after introducing their long-acting GH-deficiency treatment. Check out today's case study ???? ???????????? Our technology at Hera Health Solutions turns APIs into long-acting drugs. Send the direct message “Long-acting” to Hera’s LinkedIn inbox to explore your API’s

要查看或添加评论,请登录